The rating affirmation was based on a number of factors, including Fairview’s improved financial performance, growth in liquidity, and strong market position.
The health system’s operating cash flow margin was 8.6 percent in fiscal year 2013, up from 8 percent in 2012, and 5.2 percent in 2011. In addition, Fairview’s unrestricted cash and investments grew to $1.3 billion in fiscal year 2013, up from $1.1 billion in 2012.
Fairview also faces some challenges, such as its located in a very competitive market with several other large systems. In addition, the health system continues to experience a decline in inpatient volumes.
The revision of the rating outlook reflects the system’s improved financial performance through the first six months of fiscal year 2014, which is the third consecutive year Fairview has shown improved results.
More articles on hospital credit ratings:
Fitch assigns ‘AA-‘ rating to UPMC bonds, outlook negative
S&P: Nonprofit children’s hospitals likely to stay stable short-term
Fitch assigns ‘BBB+’ rating to Major Hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
